Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000248325

Medchemexpress LLC hVEGF-IN-1 | 1637443-98-1 | 99.3% | 581.75 g/mol | C34H43N7O2 | 100 MG
SDP

Catalog No. 5000248325
Encompass_Preferred

hVEGF-IN-1 is a quinazoline-derived small-molecule research reagent that inhibits VEGF-A expression by binding G-rich sequences within the IRES-A element and destabilizing G-quadruplex structures. It has been reported to reduce VEGF-A protein levels, hinder tumor cell migration, and suppress tumor growth in cellular assays.

  • Binds G-rich IRES-A sequence and destabilizes G-quadruplex structures.
  • Reduces VEGF-A protein expression in cellular assays.
  • Inhibits tumor cell migration and growth in vitro.
  • High chemical purity suitable for research applications.
  • Available in multiple solid and solution package sizes for experimental flexibility.

Catalog No. 50-002-48325 Supplier Medchemexpress LLC Supplier No. HY101931100MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

hVEGF-IN-1 is a quinazoline-derived small-molecule research reagent that inhibits VEGF-A expression by binding G-rich sequences within the IRES-A element and destabilizing G-quadruplex structures. It has been reported to reduce VEGF-A protein levels, hinder tumor cell migration, and suppress tumor growth in cellular assays.

  • Binds G-rich IRES-A sequence and destabilizes G-quadruplex structures.
  • Reduces VEGF-A protein expression in cellular assays.
  • Inhibits tumor cell migration and growth in vitro.
  • High chemical purity suitable for research applications.
  • Available in multiple solid and solution package sizes for experimental flexibility.

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.